Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |